We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.22B
AUM Growth
-$44.8M
Cap. Flow
+$3.01M
Cap. Flow %
0.25%
Top 10 Hldgs %
29.85%
Holding
194
New
3
Increased
55
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$950K
2
CB icon
Chubb
CB
+$761K
3
BLKB icon
Blackbaud
BLKB
+$689K
4
HXL icon
Hexcel
HXL
+$638K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$628K

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$1.84M
2
FDX icon
FedEx
FDX
+$1.8M
3
MSFT icon
Microsoft
MSFT
+$1.69M
4
SNPS icon
Synopsys
SNPS
+$1.41M
5
AAPL icon
Apple
AAPL
+$727K

Sector Composition

Rank Sector Weight
1 Technology 27.18%
2 Healthcare 16.06%
3 Industrials 11.8%
4 Financials 11.68%
5 Consumer Staples 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$64.1M 5.23%
275,127
-6,389
-2% -$1.69M
PAYX icon
2
Paychex
PAYX
$43.4B
$43.3M 3.54%
386,026
+40
+0% +$4.96K
ADI icon
3
Analog Devices
ADI
$172B
$37.3M 3.05%
267,747
-2,508
-0.9% -$397K
ALB icon
4
Albemarle
ALB
$13.4B
$36.5M 2.98%
137,888
+13
+0% +$3.31K
DEO icon
5
Diageo
DEO
$49.6B
$33.6M 2.74%
197,675
+2,366
+1% +$424K
ITW icon
6
Illinois Tool Works
ITW
$84.1B
$31.7M 2.59%
175,442
+2,190
+1% +$432K
LIN icon
7
Linde
LIN
$236B
$31.5M 2.57%
116,795
+1,223
+1% +$351K
HRL icon
8
Hormel Foods
HRL
$14.2B
$29.5M 2.41%
649,585
+6,538
+1% +$316K
JCI icon
9
Johnson Controls International
JCI
$85.1B
$29.4M 2.4%
597,403
+7,872
+1% +$417K
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.1T
$28.8M 2.35%
107,822
+725
+0.7% +$206K
CB icon
11
Chubb
CB
$140B
$27.1M 2.21%
149,005
+4,008
+3% +$761K
MRK icon
12
Merck
MRK
$322B
$26.9M 2.2%
312,808
+2,338
+0.8% +$209K
VRSK icon
13
Verisk Analytics
VRSK
$27.9B
$25.4M 2.07%
148,644
+1,238
+0.8% +$231K
ADSK icon
14
Autodesk
ADSK
$51.8B
$24.7M 2.02%
132,433
-1,285
-1% -$260K
SNPS icon
15
Synopsys
SNPS
$71.6B
$24.7M 2.02%
80,955
-4,161
-5% -$1.41M
RTX icon
16
RTX Corp
RTX
$290B
$23.9M 1.95%
292,227
+6,869
+2% +$622K
ABB
17
DELISTED
ABB Ltd
ABB
$23.2M 1.9%
905,237
+18,880
+2% +$530K
MTB icon
18
M&T Bank
MTB
$36.3B
$22.8M 1.86%
129,307
+3,431
+3% +$607K
CACI icon
19
CACI
CACI
$10.8B
$22.3M 1.82%
85,469
+1,288
+2% +$363K
APD icon
20
Air Products & Chemicals
APD
$65.5B
$22.3M 1.82%
95,640
+748
+0.8% +$185K
PYPL icon
21
PayPal
PYPL
$50.3B
$21.3M 1.74%
247,597
+2,314
+0.9% +$205K
REGN icon
22
Regeneron Pharmaceuticals
REGN
$72.9B
$20.9M 1.7%
30,272
+998
+3% +$628K
SYK icon
23
Stryker
SYK
$135B
$20.7M 1.69%
102,420
+1,201
+1% +$253K
UL icon
24
Unilever
UL
$142B
$20.5M 1.67%
415,288
+6,813
+2% +$356K
CVX icon
25
Chevron
CVX
$382B
$19.2M 1.57%
133,568
+1,221
+0.9% +$186K

Similar funds

Grandfield & Dodd's Q3 2022 Portfolio in Review

As of Q3 2022, Grandfield & Dodd held 194 positions worth $1.22B, down 3.5% from $1.27B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q3 2022 filing shows 3 new, 55 increased, 48 reduced and 9 closed positions. Its largest new stake was Genmab: 10,210 shares worth $330K. The largest sale was Brunswick, an estimated $1.84M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2022 buy was Genmab: 10,210 shares worth $330K.
  • Grandfield & Dodd added most to People Inc in Q3 2022, an estimated $950K increase.
  • Grandfield & Dodd's biggest Q3 2022 reduction was Brunswick, cutting an estimated $1.84M.
  • Grandfield & Dodd fully exited Verizon in Q3 2022, selling an estimated $420K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.22B portfolio in Q3 2022.
  • Grandfield & Dodd opened 3 new positions and closed 9 in Q3 2022.
  • Grandfield & Dodd's portfolio value fell 3.5% quarter-over-quarter to $1.22B.

Based on Grandfield & Dodd's 13F filing for Q3 2022, filed 4 Nov 2022.